The biotech company baseclick GmbH launched a new and highly efficient method for SARS-CoV-2 mutation analysis Kumar Jeetendra | January 19, 2021 Neuried, Germany – 19 January 2021 –The rapid spread of the newly emerging SARS-CoV-2 virus variant B.1.1.7 in Great Britain and other countries shows changes in the genome of the SARS-CoV-2 virus can lead to new biological properties. Most of the approximately 12,000 mutations in the genome of the SARS-CoV-2 virus that have been identified …
Ubiquigent and the University of York Awarded a Grant to Explore the Potential of Deubiquitylase (DUB) Enzyme Inhibitors to Address Neglected Tropical Diseases Kumar Jeetendra | January 16, 2021 Dundee, UK, 14th January 2021 – Ubiquigent Limited (Ubiquigent) and the Mottram Laboratory at the University of York today announced a collaboration to investigate the inhibition of deubiquitylase (DUB) enzymes expressed by the protozoan Leishmania mexicana for the treatment of leishmaniasis. The collaboration will be supported by a Global Challenges Research Fund grant, awarded by …
Sartorius to acquire Novasep’s chromatography process equipment division Kumar Jeetendra | January 13, 2021 The life science company Sartorius today announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep. The parties agreed not to disclose the purchase price until the necessary regulatory approvals have been obtained. Novasep’s division expects to generate sales revenue of approximately 37 …
HiMedia Launches a ground-breaking 11 minute Automated Viral RNA Extraction Kumar Jeetendra | January 9, 2021 In a major breakthrough, HiGenoMB®, the Molecular Biology section of HiMedia Laboratories Pvt. Ltd. launches the quickest and the easiest 11 minute automated RNA extraction protocol. The Super 11 Pre-filled Plates for Insta NX® Mag96 (MB615MPF9611) enables processing of 96 samples in just eleven minutes! In challenging times like these, the pre-filled reagents in this …
Panthera began dosing volunteers in AstraZeneca’s phase III of its long-acting antibody combination AZD7442 for the prevention of COVID-19 at its sites in Preston, North Manchester and North London Kumar Jeetendra | January 5, 2021 Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase III PROVENT trial which will evaluate AstraZeneca’s long-acting antibody combination, AZD7442, for the potential prevention of COVID-19. The double-blind, placebo-controlled trial will include adult volunteers who have no history of COVID-19 and have an increased risk of infection, …
Nordic Capital and Astorg invest in pharmaceutical technology and advanced analytics company Cytel Kumar Jeetendra | December 21, 2020 Waltham, Mass – December 21, 2020 – Nordic Capital and Astorg today announced an agreement to jointly acquire Cytel Inc. (“Cytel”), from New Mountain Capital. Cytel is one of the largest providers of statistical software and advanced analytics for clinical trial design and biometrics execution. Building on Cytel’s advanced software platform and leading biometrics services …
John Bell & Croyden celebrates key role of community pharmacists during covid-19 Kumar Jeetendra | December 16, 2020 London, UK – 16 December 2020 –John Bell & Croyden – holders of the Royal Warrant and pharmacists to Her Majesty the Queen – are celebrating the key role that community pharmacists have played during COVID-19. The renowned pharmacy emporium – who have kept their doors opened through two world wars and now a pandemic …
Sygnature Discovery invests £3m to expand high-throughput screening and translational oncology capabilities Kumar Jeetendra | December 16, 2020 Nottingham and Alderley Park, UK – 16th December 2020 – Life Science Newswire – Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical contract research organization, is strengthening its high-throughput screening (HTS) and translational oncology service-offerings by investing £3 million in new instrumentation and equipment. Sygnature’s Translational Oncology department at Alderley Park is currently …
Roche partnered with Moderna to Include Antibody Test in Covid-19 Vaccine Trials Kumar Jeetendra | December 14, 2020 Roche, Basel, Switzerland, announced a partnership with Moderna Inc., Cambridge, Mass, to utilize the Elecsys Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine research trials. This will facilitate the quantitative measurement of SARS-CoV-2 Compounds and help to establish a correlation between vaccine-induced protection and degrees of anti-receptor binding domain (RBD) antibodies. Significantly, Moderna’s vaccine triggers …
HiMedia’s Molecular Biology Division gets ICMR nod along with CE/IVD approvals for their COVID range of products Kumar Jeetendra | December 14, 2020 HiGenoMB®, the Molecular Biology Division of HiMedia Laboratories Pvt. Ltd. the leading Indian BioSciences manufacturer proudly announces that it has received the prestigious ICMR and CE/IVD approval for its COVID Range of Products. 1.Hi-PCR® Coronavirus (COVID-19) Multiplex Probe PCR Kits (MBPCR243) 2.HiPurA® Viral RNA Purification Kit (MB615) 3.HiPurA® Viral RNA Purification Kit – Magnetic Bead …
Arctoris appoints three experienced industry executives as members of its Advisory Board Kumar Jeetendra | December 10, 2020 Oxford, UK – 10 December 2020 – Life Science Newswire – Arctoris Ltd, an Oxford-based research company operating a fully automated drug discovery platform, has appointed three distinguished experts as members of its Advisory Board: Beth J Hoffman PhD, Professor Khusru Asadullah MD, and Stanley Lapidus. “We are delighted to see Dr Hoffman, Prof Asadullah …
Cytel Acquires HEOR Experts Purple Squirrel Economics Kumar Jeetendra | December 2, 2020 Waltham, MA, December 1, 2020 – Cytel Inc., a leading provider of advanced analytics for the life sciences industry, has announced the acquisition of Purple Squirrel Economics. This new deal will further expand the global reach of Cytel’s Health Economics Outcomes Research (HEOR) expertise, which spans the entirety of the clinical development journey – from …
